Literature DB >> 11268493

Prognostic significance of high microsatellite instability in a Spanish series of gastric adenocarcinomas.

P Artuñedo Pe1, M Moreno Azcoita, A Alonso, A Fernández-Peralta, J J González-Aguilera.   

Abstract

In colorectal cancer different levels of microsatellite instability (MSI) have been described. MSI-H (high) characterizes a unique clinical and pathological phenotype known as hereditary non-polyposis colorectal cancer syndrome, whereas MSI-L (low) and MSS (stable) are considered similar phenotypes without pathological implications. MSI has been also described as a frequent genetic alteration in a subset of gastric adenocarcinomas. However, the clinicopathological and prognosis significance of this abnormality in these tumors remains unclear. To investigate the role of genetic instability in gastric carcinogenesis we examined 10 microsatellite loci in 37 patients. MSI-H was found in 37.8% patients. We observed a trend of MSI-H tumors to be associated with elderly patients, intestinal histological type, advanced clinical stages and less aggressiveness with better survival. In conclusion, MSI-H can be considered as a good prognosis factor in a subset of gastric tumors.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11268493

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  2 in total

1.  Association of tumor necrosis factor genetic polymorphism with chronic atrophic gastritis and gastric adenocarcinoma in Chinese Han population.

Authors:  Bao-Ying Fei; Bing Xia; Chang-Sheng Deng; Xiao-Qing Xia; Min Xie; J Bart A Crusius; A Salvador Pena
Journal:  World J Gastroenterol       Date:  2004-05-01       Impact factor: 5.742

2.  Role of tumor necrosis factor-α -308 G/A promoter polymorphism in gastric cancer.

Authors:  Amar C Bhayal; Devulapalli Krishnaveni; Kondadasula P RangaRao; Varun Bogadi; Chowdavaram Suman; Akka Jyothy; Pratibha Nallari; Ananthapur Venkateshwari
Journal:  Saudi J Gastroenterol       Date:  2013 Jul-Aug       Impact factor: 2.485

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.